Dirk Pleimes
Impact in
-
- Multiple Sclerosis Research Studies
- Vitamin D Research Studies
- Biological Psychiatry top 10%
Papers in
- Oncology 10
- Neutropenia and Cancer Infections 5
- Cancer Treatment and Pharmacology 4
- Cytokine Signaling Pathways and Interactions 3
-
- Multiple Sclerosis Research Studies 9
- Systemic Sclerosis and Related Diseases 3
- Co-authors
- Frederik Barkhof (7 shared papers)Ludwig Kappos (7 shared papers)Xavier Montalbán (7 shared papers)Rupert Sandbrink (7 shared papers)Christoph Pohl (7 shared papers)Mark S. Freedman (5 shared papers)Gilles Edan (6 shared papers)Chris H. Polman (4 shared papers)
- Journals
- Blood (4 papers)Neurology (2 papers)Multiple Sclerosis Journal (2 papers)Journal of Clinical Oncology (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Dirk Pleimes
23 papers receiving 637 citations
Peers
Comparison fields: 5 of 80
- Pathology and Forensic Medicine 496
- Biological Psychiatry 31
- Immunology 165
- Rheumatology 105
- Neurology 105
Countries citing papers authored by Dirk Pleimes
This map shows the geographic impact of Dirk Pleimes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Pleimes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Pleimes more than expected).
Fields of papers citing papers by Dirk Pleimes
This network shows the impact of papers produced by Dirk Pleimes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Pleimes. The network helps show where Dirk Pleimes may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Pleimes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 360 | |
| 2 | 2013 | 57 | |
| 3 | 2012 | 44 | |
| 4 | 2014 | 36 | |
| 5 | 2014 | 30 | |
| 6 | 2013 | 26 | |
| 7 | 2004 | 19 | |
| 8 | 2012 | 18 | |
| 9 | 2013 | 17 | |
| 10 | 2007 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2023 | 7 | |
| 13 | 2015 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2015 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2024 | 2 | |
| 19 | Long-term effect of early treatment with interferon-beta-1b after a first clinical event suggestive of multiple sclerosis: 8-year observational extension of the phase 3 BENEFIT trial | 2011 | 1 |
| 20 | 2018 | 1 |
About Dirk Pleimes
Dirk Pleimes is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology, having authored 28 papers that have together received 659 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (9 papers), Neutropenia and Cancer Infections (5 papers), Cancer Treatment and Pharmacology (4 papers), Effects of Radiation Exposure (4 papers), Blood disorders and treatments (4 papers), Systemic Lupus Erythematosus Research (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (496 citations), Biological Psychiatry (31 citations), Immunology (165 citations), Rheumatology (105 citations) and Neurology (105 citations). Dirk Pleimes has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Frederik Barkhof, Ludwig Kappos, Xavier Montalbán, Rupert Sandbrink, Christoph Pohl, Mark S. Freedman, Gilles Edan, Chris H. Polman, Hans‐Peter Hartung and David H. Miller. Their work appears in journals such as Blood, Neurology, Multiple Sclerosis Journal, Journal of Clinical Oncology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.